Oxygenation of hypoxic region in solid tumor by administration of human serum albumin incorporating synthetic hemes

J Biomed Mater Res A. 2003 Jan 1;64(1):48-51. doi: 10.1002/jbm.a.10323.

Abstract

Recombinant human serum albumin incorporating synthetic heme (rHSA-FeP) was tested for its ability to increase O(2) tension in the hypoxia of the solid tumor rat model. By the direct administration of the rHSA-FeP solution (10 mL/kg) via the aorta descendens to the ascites hepatoma LY80 tumor on the right femur, the O(2) tension of the hypoxic region immediately increased to 3.45 +/- 1.43 Torr, which corresponds to a 2.4-fold increase compared to that of the baseline value. These high O(2) levels continued for 300 s after the infusion. The rHSA-FeP solution can be utilized not only as a red blood cell substitute but also as an O(2)-carrying medicine for the effective reoxygenation of the hypoxia solid tumor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Heme / chemistry*
  • Hypoxia / metabolism*
  • Liver Neoplasms, Experimental / metabolism*
  • Liver Neoplasms, Experimental / pathology
  • Male
  • Oxygen / administration & dosage*
  • Rats
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / chemistry
  • Serum Albumin / administration & dosage*
  • Serum Albumin / chemistry
  • Tumor Cells, Cultured

Substances

  • Recombinant Proteins
  • Serum Albumin
  • Heme
  • Oxygen